Citigroup Maintains Buy on Adient, Lowers Price Target to $29
Citigroup analyst Michael Ward maintains Adient (NYSE: ADNT ) with a Buy and lowers the price target from $33 to $29.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.